Postparacentesis bilateral massive vulvar edema in a patient with severe ovarian hyperstimulation syndrome Dimitrios Vavilis, M.D., Stergios Tzitzimikas,

Slides:

Advertisements

Similar presentations

Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice Michelle Nisolle, M.D., Ph.D., Françoise Casanas-Roux, B.S.,

Advertisements

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles Ryan G. Steward,

Maria Jose G. Teruel, Ph. D. , Luis F. Carbonell, Ph. D

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome

Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous.

Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment Javier Domingo, M.D., Vicente.

Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.

Transvaginal Drainage of Ascites as an Alternative to Abdominal Paracentesis in Patients with Severe Ovarian Hyperstimulation Syndrome, Obesity, and Generalized.

No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.

Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study Arianna D'Angelo, M.D., Rachel.

Michael P Steinkampf, M. D. , Sejal P Dharia, M. D

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Effect of the initiation of progesterone supplementation in in vitro fertilization–embryo transfer outcomes: a prospective randomized controlled trial

Day 4 Estradiol Levels Predict Pregnancy Success in Women Undergoing Controlled Ovarian Hyperstimulation for IVF John Y Phelps, M.D., Adam S Levine,

John A Rock, M.D., Carla P Roberts, MD, PhD, John S Hesla, M.D.

Angela C Meyer, M. D. , John C Papadimitriou, M. D. , Ph. D

Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model Ramiro Quintana, M.D.,

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Oocyte cryopreservation

Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian.

Vivian Barak, Ph. D. , Uriel Elchalal, M. D. , Michal Edelstein, M. D

Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis Laura P. Smith, M.D.,

Endometrial wavelike activity, endometrial thickness, and ultrasound texture in controlled ovarian hyperstimulation cycles Marga M IJland, M.D., Johannes.

From partner's desk to iPad

Mohamed Fawzy, M. D. , Mohamed Y. AbdelRahman, M. D. , Mohamed H

Reduction of ovarian torsion 1 week after embryo transfer in a patient with bilateral hyperstimulated ovaries Anil B Pinto, M.D., Valerie S Ratts, M.D.,

Varicocele: a bilateral disease

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Thomas M. D’Hooghe, M. D. , Ph. D. , Bénédicte Denys, M. D

Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,

Massimo Tartagni, M. D. , Luca Maria Schonauer, M. D

Endocrine gland–derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome.

Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D.

A retrospective study on the use of dose-dependent letrozole to decrease cancer recurrence and adverse events in patients undergoing ovarian stimulation

Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than.

Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series Nanette L. Rollene,

Pyridostigmine cotreatment for controlled ovarian hyperstimulation in low responders undergoing in vitro fertilization–embryo transfer Chung-Hoon Kim,

Regulation of assisted reproductive technologies in the United States

Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial Antoni J. Duleba, M.D.,

Hysteropyelogram Fertility and Sterility

Effect of endometriosis on in vitro fertilization

Lindsay M. Mains, M. D. , Babak Vakili, M. D. , Yves Lacassie, M. D

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

A case of ovarian hyperstimulation syndrome associated with the methylenetetrahydrofolate reductase mutation gene Filippo Ferrara, M.D., Francesco Meli,

Cabergoline and Ganirelix Therapy for Early Moderate to Severe Ovarian Hyperstimulation Syndrome (OHSS) Results in Faster Recovery than in Early Untreated.

Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D.

Effect of angiotensin-converting enzyme inhibitor on renal function in ovarian hyperstimulation syndrome in the rabbit Maria Jose G Teruel, Ph.D., Luis.

Fertility and Sterility: an evaluation

George Pados, M. D. , Dimitrios Vavilis, M. D

Sedigheh Borna, M.D., Azita Nasery, M.D. Fertility and Sterility

Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis Ernesto Bosch, M.D., Elena.

Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin- releasing hormone agonist short regimen on alternate days and an antagonist.

Percutaneous oocyte retrieval from an inguinal ovary

Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndome Yoram Abramov, M.D., Joseph.

Does elevated human chorionic gonadotropin alone trigger spontaneous ovarian hyperstimulation syndrome? Rachel Michaelson-Cohen, M.D., Gheona Altarescu,

The J-Tip Needle-Free Injection System in controlled ovarian hyperstimulation in in vitro fertilization: a pilot study Stuart A. Lavery, M.R.C.O.G.,

Altered osmotic thresholds for arginine vasopressin secretion and thirst during superovulation and in the ovarian hyperstimulation syndrome (OHSS): relevance.

Diane De Neubourg, M. D. , Kathelijne Mangelschots, B. Sc

Effectiveness of human menopausal gonadotropin versus recombinant follicle- stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive.

Tubal sterilization: focus on the U.S. experience

William R. Boone, Ph. D. , Jeffrey M. Jones, Ph. D. , Sander S

Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome

Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test Dimitrios Panidis, M.D., Ph.D., Dimitrios.

Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: “Tap early and often” versus hospitalization John.

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing.

Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome Kris Poppe, M.D., Ph.D., David Unuane,

Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles2

P-24 Fertility and Sterility Volume 85, Pages S19-S20 (April 2006)

Stephen J Winters, M. D. , Evelyn Talbott, David S Guzick, Ph. D. , M

Presentation transcript:

Postparacentesis bilateral massive vulvar edema in a patient with severe ovarian hyperstimulation syndrome Dimitrios Vavilis, M.D., Stergios Tzitzimikas, M.D., Theodoros Agorastos, M.D., Aristotelis Loufopoulos, M.D., Trifon Tsalikis, M.D., John N Bontis, M.D., Ph.D. Fertility and Sterility Volume 77, Issue 4, Pages 841-843 (April 2002) DOI: 10.1016/S0015-0282(01)03248-4

FIGURE 1 Massive vulvar edema 24 hours after paracentesis. Vavilis. Vulvar edema in OHSS. Fertil Steril 2002. Fertility and Sterility 2002 77, 841-843DOI: (10.1016/S0015-0282(01)03248-4)